Valuation: Sartorius Stedim Biotech

Market Cap 18.6B 21.71B 17.4B 15.91B 30.03B 2,079B 30.34B 206B 80.08B 1,044B 81.5B 79.74B 3,453B P/E 2026 *
49x
P/E 2027 * 38x
Enterprise Value 20.61B 24.05B 19.28B 17.63B 33.27B 2,303B 33.62B 228B 88.73B 1,156B 90.31B 88.35B 3,826B EV / Sales 2026 *
6.59x
EV / Sales 2027 * 5.87x
Free-Float
28.47%
Yield 2026 *
0.43%
Yield 2027 * 0.53%
1 week+5.14%
Current month+14.15%
1 month+14.29%
3 months+12.13%
6 months+6.07%
Current year-7.44%
1 week 178.7
Extreme 178.7
195
1 month 161.1
Extreme 161.1
195
3 years 139.8
Extreme 139.8
279.1
5 years 139.8
Extreme 139.8
557.2
10 years 51.12
Extreme 51.12
557.2
Manager TitleAgeSince
Chief Executive Officer 51 2023-03-27
Chief Tech/Sci/R&D Officer 61 2011-09-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 69 2015-04-06
Director/Board Member 69 2017-09-13
Change 5-day change 1-year change 3-year change Capi.($)
+1.16%+5.14%+8.00%-24.17% 21.71B
-0.93%+2.34%-12.55%+10.66% 202B
-1.12%-0.82%-0.77%+11.13% 119B
+0.20%+2.92%+12.85%+81.28% 61.78B
+0.40%-5.32%+30.83%+55.98% 52.35B
-0.90%+4.26%-3.18%-32.69% 51.96B
-0.69%+1.10%+19.25%-10.10% 34.36B
+0.13%+2.01% - - 30.44B
-0.75%+1.18%+41.85%-10.94% 24.87B
+0.04%-0.90%-5.19%+24.89% 24.07B
Average -0.46%+1.45%+10.12%+11.78% 66.74B
Weighted average by Cap. -0.69%+2.83%+2.31%+15.51%

Financials

2026 *2027 *
Net sales 3.13B 3.65B 2.92B 2.67B 5.05B 349B 5.1B 34.61B 13.46B 175B 13.7B 13.4B 580B 3.47B 4.05B 3.24B 2.97B 5.6B 387B 5.66B 38.39B 14.93B 195B 15.19B 14.86B 644B
Net income 379M 442M 355M 324M 612M 42.35B 618M 4.2B 1.63B 21.27B 1.66B 1.62B 70.36B 481M 561M 450M 411M 776M 53.74B 785M 5.32B 2.07B 26.98B 2.11B 2.06B 89.28B
Net Debt 2.01B 2.35B 1.88B 1.72B 3.24B 225B 3.28B 22.25B 8.65B 113B 8.8B 8.61B 373B 1.76B 2.06B 1.65B 1.51B 2.84B 197B 2.87B 19.5B 7.58B 98.81B 7.72B 7.55B 327B
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
-
Date Price Change
26-08-25 193.00 +1.37%
26-08-24 €190.40 -1.30%
26-08-21 €192.90 -0.41%
26-08-20 €193.70 +6.20%
26-08-19 €182.40 +1.11%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
191.20EUR
Average target price
232.64EUR
Spread / Average Target
+21.68%

Quarterly revenue - Rate of surprise